TET2 and acute myeloid leukemia: Having observed the skipping of TET2 exon 2 in AraC-resistant AML cells and in diagnosis samples from patients with chemosensitive disease, we were interested to check the status of the TET2 exon 2 in our series of 152 AML samples.